Developing medicines for rare diseases requires a highly specialized approach. Unlike therapies intended for large patient populations, rare disease programs often involve limited patient numbers, complex biological targets, specialized formulations, and unique manufacturing requirements. In this environment, access to the…
Modern pharmaceutical formulations are becoming increasingly complex as manufacturers work to improve drug stability, bioavailability, patient convenience, and overall product performance. While active pharmaceutical ingredients (APIs) provide the therapeutic effect, functional excipients play an equally important role in helping create…
High-Potency Active Pharmaceutical Ingredients (HPAPIs) are becoming increasingly important in modern pharmaceutical development, particularly for therapies that require highly potent compounds at very low doses. For Canadian pharmaceutical manufacturers, sourcing these specialized ingredients involves more than simply finding an available…
